Gehrisch S - Search Results

1

Standardized use of novel oral anticoagulants plasma level thresholds in a new thrombolysis decision making protocol.

Kepplinger J, Prakapenia A, Barlinn K, Siegert G, Gehrisch S, Zerna C, Beyer-Westendorf J, Puetz V, Reichmann H, Siepmann T, Bodechtel U. Kepplinger J, et al. Among authors: gehrisch s. J Thromb Thrombolysis. 2016 Feb;41(2):293-300. doi: 10.1007/s11239-015-1229-z. J Thromb Thrombolysis. 2016. PMID: 26001908 Clinical Trial.

2

Coagulation activation after discontinuation of VTE treatment with different oral anticoagulants and impact on 12-month clinical outcomes.

Beyer-Westendorf J, Gehrisch S, Stange T, Tittl L, Siegert G, Weiss N. Beyer-Westendorf J, et al. Among authors: gehrisch s. Thromb Res. 2015 Aug;136(2):261-6. doi: 10.1016/j.thromres.2015.06.003. Epub 2015 Jun 10. Thromb Res. 2015. PMID: 26071672

3

Pharmacokinetics of rivaroxaban after bariatric surgery: a case report.

Mahlmann A, Gehrisch S, Beyer-Westendorf J. Mahlmann A, et al. Among authors: gehrisch s. J Thromb Thrombolysis. 2013 Nov;36(4):533-5. doi: 10.1007/s11239-013-0891-2. J Thromb Thrombolysis. 2013. PMID: 23417780

4

Phamacokinetics of rivaroxaban in adolescents.

Beyer-Westendorf J, Gehrisch S. Beyer-Westendorf J, et al. Among authors: gehrisch s. Hamostaseologie. 2014;34(1):85-7. doi: 10.5482/HAMO-13-06-0033. Epub 2013 Oct 24. Hamostaseologie. 2014. PMID: 24154682

5

Interaction of clopidogrel and statins in secondary prevention after cerebral ischaemia - a randomized, double-blind, double-dummy crossover study.

Siepmann T, Heinke D, Kepplinger J, Barlinn K, Gehrisch S, Grählert X, Schwanebeck U, Reichmann H, Puetz V, Bodechtel U, Gahn G. Siepmann T, et al. Among authors: gehrisch s. Br J Clin Pharmacol. 2014 Nov;78(5):1058-66. doi: 10.1111/bcp.12416. Br J Clin Pharmacol. 2014. PMID: 24803100 Free PMC article. Clinical Trial.

6

Method-dependent influence of certain polymorphisms in the factor V B-domain on the response to activated protein C.

Siegert G, Kostka H, Gehrisch S, Schwarz T, Schellong S, Jaross W. Siegert G, et al. Among authors: gehrisch s. Blood Coagul Fibrinolysis. 2000 Sep;11(6):519-27. doi: 10.1097/00001721-200009000-00003. Blood Coagul Fibrinolysis. 2000. PMID: 10997791

7

Clinical and laboratory phenotypes associated with the aspirin-like defect: a study in 17 unrelated families.

Rolf N, Knoefler R, Bugert P, Gehrisch S, Siegert G, Kuhlisch E, Suttorp M. Rolf N, et al. Among authors: gehrisch s. Br J Haematol. 2009 Feb;144(3):416-24. doi: 10.1111/j.1365-2141.2008.07468.x. Epub 2008 Nov 19. Br J Haematol. 2009. PMID: 19036102 Free article.

8

A 3-day delay in synovial fluid crystal identification did not hinder the reliable detection of monosodium urate and calcium pyrophosphate crystals.

Tausche AK, Gehrisch S, Panzner I, Winzer M, Range U, Bornstein SR, Siegert G, Wunderlich C, Aringer M. Tausche AK, et al. Among authors: gehrisch s. J Clin Rheumatol. 2013 Aug;19(5):241-5. doi: 10.1097/RHU.0b013e31829cde53. J Clin Rheumatol. 2013. PMID: 23872540

9

[Clinical and laboratory aspects of the Aspirin-like defect as hereditary thrombocytopathy].

Rolf N, Bugert P, Gehrisch S, Siegert G, Suttorp M, Knöfler R. Rolf N, et al. Among authors: gehrisch s. Hamostaseologie. 2009 May;29(2):177-83. Hamostaseologie. 2009. PMID: 19404514 German.

10

New missense mutation in exon 13 (N789T) of the coagulation factor V gene.

Kostka H, Siegert G, Gehrisch S, Kuhlisch E, Runge E, Jaross W. Kostka H, et al. Among authors: gehrisch s. Hum Mutat. 1999 Oct;14(4):357. doi: 10.1002/(SICI)1098-1004(199910)14:4<357::AID-HUMU23>3.0.CO;2-3. Hum Mutat. 1999. PMID: 10502835 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page